Comparative analysis between the WHO and WOAH classifications for veterinary antimicrobials in Brazil
DOI:
https://doi.org/10.5902/2179460X91915Keywords:
Antibiotic therapy, Resistance genes, One HealthAbstract
Most antimicrobials used globally in human medicine are also employed in animal treatment, increasing the risk of antimicrobial resistance. In this context, the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) classified antimicrobials according to their importance in human and veterinary health. This study analyzed the antimicrobial molecules commercially available in Brazil for animal use, comparing their classifications based on WHO and WOAH criteria. Data was collected by consulting the Business Intelligence panel of the Ministry of Agriculture and Livestock (MAPA). A total of 742 registered drugs were identified, comprising 70 distinct antimicrobial molecules, totaling 888 occurrences in different drug formulation combinations. Among these molecules, 55.2% were considered Highly Important Antimicrobials (HIA) by the WHO, while 85.5% were categorized as Critically Important Veterinary Antimicrobial Agents (VCIA) by the WOAH. Divergences in classifications between the organizations were observed, highlighting potential challenges for veterinarians in clinical decision-making.
Downloads
References
Ballash, G. A., Parker, E. M., Mollenkopf, D. F., & Wittum, T. E. (2024). The One Health dissemination of antimicrobial resistance occurs in both natural and clinical environments. Journal of the American Veterinary Medical Association, 1(aop), 1-8. Doi: 10.2460/javma.24.01.0056.
Biswas, S., Maggi, R. G., Papich, M. G., Keil, D., & Breitschwerdt, E. B. (2010). Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human. Journal of clinical microbiology, 48(2), 617-618. Doi: 10.1128/jcm.01287-09.
Blondeau, J. M., & Fitch, S. D. (2024). Comparative In vitro killing by pradofloxacin in comparison to ceftiofur, enrofloxacin, florfenicol, marbofloxacin, tildipirosin, tilmicosin and tulathromycin against bovine respiratory bacterial pathogens. Microorganisms, 12(5), 996. Doi: 10.3390/microorganisms12050996.
Boqvist, S., Söderqvist, K., & Vågsholm, I. (2018). Food safety challenges and One Health within Europe. Acta Veterinaria Scandinavica, 60, 1-13.Doi: 10.1186/s13028-017-0355-3.
Borham, M., Oreiby, A., El-Gedawy, A., Hegazy, Y., Khalifa, H. O., Al-Gaabary, M., & Matsumoto, T. (2022). Review on bovine tuberculosis: an emerging disease associated with multidrugresistant Mycobacterium species. Pathogens, 11(7), 715. Doi: 10.3390/pathogens11070715.
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. (2020, janeiro 13). Instrução Normativa nº 1 de 13 de janeiro de 2020: Proíbe, em todo o território nacional, a importação e a fabricação da substância antimicrobiana sulfato de colistina, com a finalidade de aditivo zootécnico melhorador de desempenho na alimentação animal. Diário Oficial da União, seção 1, p. 6. https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/alimentacao-animal/arquivos-alimentacao-animal/legislacao/INM000000012020.pdf
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. (2009, julho 9). Instrução Normativa nº 26 de 9 de julho de 2009: Estabelece normas sobre o controle de produtos de uso veterinário e dá outras providências. Diário Oficial da União, seção 1, p. 3. https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/alimentacaoanimal/arquivos-alimentacao-animal/legislacao/instrucao-normativa-no-26-de-9-dejulho-de-2009.pdf
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. (2016, novembro 22). Instrução Normativa nº 45 de 22 de novembro de 2016: Proíbe, em todo o território nacional, a importação, a fabricação, a comercialização e o uso de aditivos melhoradores de desempenho que contenham os antimicrobianos tilosina, lincomicina e tiamulina, classificados como importantes na medicina humana. Diário Oficial da União, seção 1, p. 6. https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/resistenciaaos-antimicrobianos/legislacao/INSTRUONORMATIVAN45DE22DENOVEMBRODE2016.pdf
Brasil. Ministério da Agricultura, Pecuária e Abastecimento. (2017, março 3). Instrução Normativa SDA nº 10, de 3 de março de 2017: Estabelece o Regulamento Técnico do Programa Nacional de Controle e Erradicação da Brucelose e da Tuberculose Animal – PNCEBT. Diário Oficial da União, seção 1, p. 3. https://www.gov.br/agricultura/pt-br/assuntos/sanidade-animal-evegetal/saude-animal/programas-de-saude-animal/pncebt/principais-normas-pncebt/in-10-de-3-de-marco-de-2017-aprova-o-regulamento-tecnico-do-pncebt.pdf
De Briyne, N., Atkinson, J., Borriello, S. P., & Pokludová, L. (2014). Antibiotics used most commonly to treat animals in Europe. Veterinary Record, 175(13), 325-325. Doi: 10.1136/vr.102462.
Chen, L., Kumar, S., & Wu, H. (2023). A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance. Archives of Microbiology, 205(11), 356. Doi: 10.1007/s00203-023-03699-2.
Costa Junior, J. L. S. da. (2018). Avaliação do conhecimento sobre medicamentos dos proprietários de cães e gatos em Aracaju/SE [Evaluation of knowledge about medications among dog and cat owners in Aracaju/SE] (Undergraduate thesis, Universidade Federal de Sergipe). https://ri.ufs.br/handle/riufs/10709.
Estany-Gestal, A., Salgado-Barreira, A., & Vazquez-Lago, J. M. (2024). Antibiotic Use and Antimicrobial Resistance: A Global Public Health Crisis. Antibiotics, 13(9), 900. Doi: 10.3390/antibiotics13090900.
European Medicines Agency. (2022). Sales of veterinary antimicrobial agents in 31 European countries: Trends from 2010 to 2022: Thirteenth ESVAC report. European Medicines Agency. https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobialagents-31-european-countries-2022-trends-2010-2022-thirteenth-esvac-report_en.pdf.
Fleming, A. (1945). Penicillin: Nobel lecture. The Nobel Prize. https://www.nobelprize.org/prizes/medicine/1945/fleming/lecture/.
Gehring, R., Mochel, J. P., & Schmerold, I. (2023). Understanding the background and clinical significance of the WHO, WOAH, and EMA classifications of antimicrobials to mitigate antimicrobial resistance. Frontiers in Veterinary Science, 10, 1153048. Doi: 0.3389/fvets.2023.1153048.
Hao, H., Cheng, G., Iqbal, Z., Ai, X., Hussain, H. I., Huang, L., ... & Yuan, Z. (2014). Benefits and risks of antimicrobial use in food-producing animals. Frontiers in microbiology, 5, 288. Doi: 10.3389/fmicb.2014.00288.
Hsieh, S. H., Huang, H. Y., & Lee, S. (2009). Determination of eight penicillin antibiotics in pharmaceuticals, milk and porcine tissues by nano-liquid chromatography. Journal of Chromatography A, 1216(43), 7186-7194. D: 10.1016/j.chroma.2009.05.080.
Marques, D. B., de Barros, N. B., & da Silva Lima, M. (2021). Os riscos da chlamídea trachomatis em mulheres grávidas e os efeitos dos diferentes fármacos utilizados para o tratamento. Brazilian Journal of Health Review, 4(3), 9845-9860. Doi: 10.34119/bjhrv4n3-023.
McEwen, S. A., & Collignon, P. J. (2018). Antimicrobial resistance: a one health perspective. Antimicrobial resistance in bacteria from livestock and companion animals, 521-547. Doi: 10.1128/9781555819804.ch25.
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., ... & Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext.
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., ... & Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext.
Oliveira, F. S., Paz, L. N., Mota, T. M., Oriá, A. P., Silva, M. C. A. D., & Pinna, M. H. (2016). Perfil de resistência de isolados de Escherichia coli a partir de piometra canina. Ciência animal brasileira, 17, 615-621. Doi: 10.1590/1089-6891v17i438817.
Organização Pan-Americana da Saúde/Ministério da Agricultura, Pecuária e Abastecimento (OPAS/MAPA). (2022). Atualização sobre uso racional de antimicrobianos e boas práticas de produção. https://www.gov.br/agricultura/pt-br/assuntos/insumos-agropecuarios/insumos-pecuarios/resistencia-aos-antimicrobianos/publicacoes/Apostila_AtualizaosobreUsoRacionaldeAntimicrobianoseBoasPrticasdeProduo.pdf
O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. https://www.amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf.
Pereira, I. A., Soares, L. C., Coelho, S. M. O., Balbino, F. A., Pribul, B. R., & Souza, M. M. S. (2009). Azithromycin susceptibility pattern of bacterial isolated from different sites of infections in pet animals. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 61, 577-584. Doi: 10.1590/S0102-09352009000300009.
Rached, R. Z., & Grotto, D. (2023). Uso de antibióticos na medicina veterinária brasileira: situação e regulamentação. CONTRIBUCIONES A LAS CIENCIAS SOCIALES, 16(9), 17090–17107. Doi: 10.55905/revconv.16n.9-195.
Ranjbar, R., & Alam, M. (2023). Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Evidence-based nursing. Doi: 10.1136/ebnurs-2022-103540.
Retsema, J. (1999). Susceptibility and resistance emergence studies with macrolides. International journal of antimicrobial agents, 11, S15-S21. Doi: 10.1016/S0924-8579(98)00099-5.
de Souza Santos, A., de Lima, D. C. V., Abad, A. C. A., de Oliveira, P. R. F., da Silva, J. G., de Moura, G. S., ... & Mota, R. A. (2020). Antimicrobial resistance profile of non-aureus Staphylococci isolates from buffalo, goat and sheep mastitis in the Northeast region of Brazil. Journal of Dairy Research, 87(3), 290-294. Doi: 10.1017/S0022029920000771.
Sato, T., Okubo, T., Usui, M., Yokota, S. I., Izumiyama, S., & Tamura, Y. (2014). Association of veterinary third-generation cephalosporin use with the risk of emergence of extendedspectrum-cephalosporin resistance in Escherichia coli from dairy cattle in Japan. PloSone, 9(4), e96101. Doi: 10.1371/journal.pone.0096101.
Serpa, M., do Nascimento, J. A. F. B., Alves, M. F., Guedes, M. I. M. C., Reis, A. T., Heinemann, M. B., ... & Dorneles, E. M. S. (2020). Antimicrobial resistance in bacteria isolated from pigs with respiratory clinical signs in Brazil. Brazilian Journal of Veterinary Research and Animal Science, 57(1), e160956-e160956. Doi: 10.11606/issn.1678-4456.bjvras.2020.160956.
Souza, M. M., Bordin, J. T., Pavan, A. C. L., Rodrigues, R. G., Sfaciotte, R. A., Vignoto, V. K., ... & Wosiacki, S. R. (2020). Avaliação da resistência antimicrobiana de bactérias isoladas de infecções em pequenos animais na região de Umuarama, Paraná. Pesquisa Veterinária Brasileira, 40, 804-813. Doi: 10.1590/1678-5150-PVB-6420.
Sykes, J. E., & Blondeau, J. M. (2014). Pradofloxacin: A novel veterinary fluoroquinolone for treatment of bacterial infections in cats. The Veterinary Journal, 201(2), 207–214. Doi: 10.1016/j.tvjl.2014.06.008.
Taylor, E. A., Ossa‐Trujillo, C., Vinasco, J., Jordan, E. R., García Buitrago, J. A., Hagevoort, R., ... & Scott, H. M. (2021). Use of critically important antimicrobial classes early in life may adversely impact bacterial resistance profiles during adult years: potential co‐selection for plasmid‐borne fluoroquinolone and macrolide resistance via extended‐spectrumbeta‐lactam use in dairy cattle. Letters in applied microbiology, 72(3), 220-224. Doi: 10.1111/lam.13419.
Van Boeckel, T. P., Glennon, E. E., Chen, D., Gilbert, M., Robinson, T. P., Grenfell, B. T., ... & Laxminarayan, R. (2017). Reducing antimicrobial use in food animals. Science, 357(6358), 1350–1352. Doi: 10.1126/science.aao1495.
Van Cutsem, J. (2023). The psychophysiological markers of mental fatigue and its carryover effects. International Journal of Psychophysiology, 188, 53. Doi: 10.1016/j.ijpsycho.2023.05.134.
Vaz, D. W. N., de Sousa, Y. M., Cavalcante, R. L., Almeida, M. D. G. C., Lima, K. V. B., & da Silva Júnior, A. F. (2021). Avaliação microbiológica dos leitos cirúrgicos de um hospital público oncológico da região norte do Brasil. Research, Society and Development, 10(1), e16610111602-e16610111602. Doi: 10.33448/rsd-v10i1.11602.
Vázquez-Chacón, C. A., Rodríguez-Gaxiola, F. D. J., López-Carrera, C. F., Cruz-Rivera, M., Martínez-Guarneros, A., Parra-Unda, R., ... & López-Durán, P. A. (2021). Identification of drug resistance mutations among Mycobacterium bovis lineages in the Americas. PLoS Neglected Tropical Diseases, 15(2), e0009145. Doi: 10.1371/journal.pntd.0009145.
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277. https://pmc.ncbi.nlm.nih.gov/articles/PMC4378521/.
World Health Organization. (2023). Global tuberculosis report 2023. World Health Organization. https://iris.who.int/handle/10665/370232.
World Health Organization. (2024). List of medically important antimicrobials – A risk management tool for mitigating antimicrobial resistance due to non-human use. World Health Organization. https://www.who.int/news/item/08-02-2024-who-medically-important-antimicrobiallist-202.
World Organisation for Animal Health. (2024a). 91st General session – Antimicrobial resistance working group report. World Organisation for Animal Health. https://www.woah.org/app/uploads/2024/05/91gs-tech-03-amr-working-group-report-en.pdf.
World Organisation for Animal Health. (2022b). Annual report on antimicrobial agents intended for use in animals (6th ed.). World Organisation for Animal Health. https://www.woah.org/app/uploads/2022/06/a-sixth-annual-report-amu-final.pdf.
World Organisation for Animal Health. (2024b). Annual report on antimicrobial agents intended for use in animals (8th ed.). World Organisation for Animal Health. https://www.woah.org/app/uploads/2024/05/woah-amu-report-2024-final.pdf.
World Organisation for Animal Health. (2022a). Implementation of WOAH standards: The Observatory annual report publication series. World Organisation for Animal Health. https://doc.woah.org/dyn/portal/index.xhtml?page=alo&aloId=42966.
World Organisation for Animal Health. (2021). List of antimicrobial agents of veterinary importance. World Organisation for Animal Health. https://www.woah.org/app/uploads/2021/06/aoie-list-antimicrobials-june2021.pdf.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ciência e Natura

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
To access the DECLARATION AND TRANSFER OF COPYRIGHT AUTHOR’S DECLARATION AND COPYRIGHT LICENSE click here.
Ethical Guidelines for Journal Publication
The Ciência e Natura journal is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.
In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review Articles should also be objective, comprehensive, and accurate accounts of the state of the art. The Authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding Author should ensure that there is a full consensus of all Co-authors in approving the final version of the paper and its submission for publication.
Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An Editor must not use unpublished information in the editor's own research without the express written consent of the Author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.
Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that Authors can use them for improving the paper. Any selected Reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the Editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.


